Cargando…
Cost-effectiveness of phosphate binders among patients with chronic kidney disease not yet on dialysis: a long way to go
Hyperphosphatemia management is integral to the management of patients with chronic kidney disease. This mineral abnormality is associated with greater costs, but so is its management, especially with the use novel phosphate binders. The economic evaluation of these pharmaceutical agents is increasi...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2016
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4938934/ https://www.ncbi.nlm.nih.gov/pubmed/27393192 http://dx.doi.org/10.1186/s12882-016-0286-7 |